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Abstract 
This study aimed to investigate the presence of resistance genes in multidrug-resistant A. baumannii isolates as well as to 
determine the antibacterial activity of selected plant extracts against isolates. 41 strains were isolated from various clinical 
samples. PCR tests were performed using the primers. Methanol was used as solvent for the preparation of the plant extracts. 
MIC values of the plant extracts were determined by the broth microdilution method. The blaOXA-23, blaCTX-M-1, blaCTX-M-2, 
blaGES genes and Class 1 integrons were detected in five isolated strains. The lowest MIC value (2.25 mg/mL) was 
determined for the Echinacea purpurea extract, while the highest MIC value (50 mg/mL) was determined for the Morus alba 
extract. Determination of the antibacterial effect of plants extracts used in the study against A. baumannii isolates shows the 
importance of screening the antibacterial activity of plants in the fight against antibiotic resistance. 
 
Rezumat 
Studiul a avut ca scop investigarea genelor de rezistență ale izolatelor de A. baumannii multirezistente, precum și 
determinarea activității antibacteriene a unor extracte vegetale supra a 41 specii microbiene izolate din diferite probe clinice. 
Metanolul a fost folosit ca solvent de extracție. Valorile concentrației minime inhibitorii ale extractelor obținute au fost 
determinate prin metoda microdiluției. Genele blaOXA-23, blaCTX-M-1, blaCTX-M2 și blaGES, alături de integroni din clasa 1 au 
fost decelate pentru 5 specii izolate. Valoarea MIC cea mai scăzută (2,25 mg/mL) a fost obținută pentru extractul din 
Echinaceea purpurea, în timp ce cea mai mare valoare MIC (50 mg/mL) a fost determinată pentru extractul de Morus alba. 
Determinarea efectului antibacterian ale extractelor vegetale împotriva izolatelor de A. baumannii arată importanța screening-
ului activității antibacteriene a plantelor în lupta împotriva rezistenței la antibiotice. 
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Introduction 
A. baumannii, a Gram-negative, nosocomial pathogen 
resistant to most current antibiotics, has become a 
major challenge for modern healthcare systems [1, 2]. 
A. baumannii, as free-living planktonic cells or bio-
films, can live at a wide range of temperature, pH 
and humidity levels. It also uses various carbon and 
energy sources to survive. These characteristics contribute 
to the persistence and spread of A. baumannii in the 
hospital setting [1, 3, 4]. Recently, isolates with 
resistance to all known antibiotics have emerged and 
are therefore considered to be one of the most dangerous 
hospital pathogens worldwide [5, 6]. A. baumannii 
often causes pneumonia, bacteraemia, meningitis, and 
wound and urinary tract infections [7]. 
A. baumannii isolates resistant to more than two anti-
biotic groups (ampicillin-sulbactam, fluoroquinolones, 
aminoglycosides, cephalosporins and antipseudomonal 
carbapenems) are defined as MDR (multidrug-resistant) 
[5, 6]. The antimicrobial resistance mechanism in A. 
baumannii is divided into three categories: (i) enzymatic 
inactivation of antimicrobials; (ii) modification of 
antimicrobial targets; and (iii) reduced access to anti-
microbial targets due to membrane modifications [8]. 
Enzymatic degradation by the β-lactamases in A. 
baumannii is the most common mechanism of β-lactam 
resistance [9]. The β-lactamases are divided into four 
groups as class A, class B (metallo β-lactamases), 
class C and class D (oxacillinases) [9]. Class A (TEM, 
SHV, CTX-M1, CTX-M2, VEB), class B (VIM, IMP), 
class C (AmpC) and class D (OXA-23, OXA-24, 
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OXA-51, OXA-58) β-lactamases have been reported 
worldwide in A. baumannii isolates [9]. The naturally 
occurring class D (OXA) carbapenemases in A. 
baumannii are the leading cause of carbapenem 
resistance in this microorganism [9]. 
Plants are capable of synthesizing secondary metabolites 
known as phytochemical compounds that act as plant 
defence mechanisms against macro and microorganisms 
[5, 10]. In many cultures in Asia, Africa and some 
parts of America, traditional medicine has been used 
for decades to protect human health and also to treat 
various diseases [11]. Alkaloids, flavonoids, phenolics 
and tannins are among the most important phyto-
chemicals used in phytotherapy [5, 12]. In recent years, 
many researchers have pointed out the role of plant 
antibacterial activities in fighting antibiotic resistant 
bacteria [13]. The efficacy of plant-derived compounds 
in controlling various MDR pathogens, including 
Acinetobacter sp., is being investigated [1]. 
Considering these points, the present study investigated 
the presence of antibiotic resistance genes and Class 1 
integrons in multidrug-resistant A. baumannii isolates 
from intensive care unit patients, and the effects on 
these isolates of methanol extracts from nine selected 
plants (Morus alba, Zingiber officinale, Vaccinium 
myrtillus, Rosa canina, Hypericum perforatum, Lycium 
barbarum, Aquilaria agallocha, Nigella sativa and 
Echinacea purpurea) were determined. 
 
Materials and Methods 
Forty-one A. baumannii strains isolated from various 
clinical specimens (tracheal aspirate, blood, urine, 
broncho-alveolar lavage) of patients hospitalized in the 
Rize Training and Research Hospital Intensive Care 
Unit, Turkey, were identified and their antibiograms 
were performed via the Vitek 2 Compact automated 
system. Isolation of DNA from the bacteria was 
performed using the DNA boiling method [14]. 
PCR tests were performed using primers of blaVIM, 
blaNDM, blaIMP, blaGES, blaCTXM-1, blaCTXM-2, blaOXA-58, 
blaOXA-23, blaOXA-51 and Class 1 integrons [15]. The 
PCRs were performed in a final volume of 50 μL. The 
PCR component mix was as follows: 5 μL of genomic 
DNA, 2 μL of each primer (20 pmol/μL), 10 μL reaction 
buffer (Promega, Madison, WI, USA), 3 μL 25 mM 
MgCl2, 4 μL of each dNTP (2.5 mM) and 1.5 U of 
GoTaq
®
 Flexi Polymerase (Promega, Madison, WI, 
USA). All PCR results were run on 1% agarose gel 
containing 0.5 μg/mL ethidium bromide and then 
visualized under ultraviolet (UV) light.
 
When choosing the plants to be used in the study, 
those which are frequently studied in the literature and 
widely consumed and utilized by people for various 
purposes were preferred. Morus alba, Zingiber officinale, 
Vaccinium myrtillus, Rosa canina, Hypericum perforatum, 
Lycium barbarum, Aquilaria agallocha, Nigella sativa 
and Echinacea purpurea were purchased as dry and 
ground from a local herbal shop. To ensure that each 
of the samples was completely and uniformly dried, 
they were oven dried and weighed at intervals for seven 
days. Samples (10 g) of each of the powdered plants 
were then extracted with 100 mL of methanol for 2 h 
using a magnetic stirrer. At the end of the process, 
the plant extracts were first filtered through Blue 
Ribbon filter paper and in the second stage, through 
0.25 µM filters. The clarified plant extracts were placed 
in glass flasks and their solvents were completely 
evaporated in a rotary evaporator. Their concentrations 
were determined by dissolving each in a specific volume 
of methanol. The extracts were then stored in a cool, 
dark environment until analysis. 
The broth microdilution method was used to determine 
the MIC of the plant extracts against A. baumannnii 
isolates. Experiments were performed in triplicate 
using 96-well plates. Ampicillin was used as control 
at concentrations of 100 - 0.78125 mg/mL. All isolates 
were grown on LB (Luria Bertani) medium at 37°C. 
In the first 11 wells, 50 μL of LB broth was placed, 
while, as a sterility control, 100 μL of LB broth was 
added to the 12
th
 well and evaluated. In addition, the 
11
th
 well was prepared as a growth control with 50 μL 
LB broth + 50 μL bacteria. Serial dilutions were made 
up to the 10
th
 well, starting with 50 μL of the first 
concentration of extracts placed into the first well. 
Plates were incubated at 37°C and MIC values were 
determined as the concentration of the plant extract 
in the first well where no growth had occurred [16]. 
 
Results and Discussion 
Identification and antibiograms of 41 A. baumannii 
strains isolated from various clinical specimens (tracheal 
aspirate, blood, urine and bronchoalveolar lavage) of 
patients hospitalized in the Rize Training and Research 
Hospital Intensive Care Unit, Turkey, were studied 
using the Vitek 2 Compact automated system. Antibiotic 
resistance profiles of the 41 identified A. baumannii 
isolates are shown in Table I. The blaOXA-51 gene was 
used to identify A. baumannii isolates, and this gene 
was detected in all of the isolates included in this 
study. In 38 isolates, the blaOXA-23 (92.6%) class D 
β-lactamase gene was detected. Among the Class A 
β-lactamase genes, blaCTXM-1 was detected in 36 isolates 
(87.8%), blaCTXM-2 in 18 isolates (43%) and blaGES 
in 1 isolate. The presence of the studied metallo β-
lactamase genes (blaVIM, blaNDM and blaIMP) and the 
blaOXA-58 gene encoding Class D β-lactamase was 
not observed in any isolate. Class 1 integrons were 
detected in 34 isolates. 
Most of the A. baumannii pathogens were isolated from 
the respiratory tract of hospitalized patients [9]. The 
clinical effect of Acinetobacter increases morbidity or 
mortality and A. baumannii infections are responsible 
for the increase in patient deaths in critically ill patients. 
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Many studies have shown that A. baumannii has a high 
rate of multiple drug resistance (MDR) [9]. 
Table I 
Antibiotic resistance rates of A. baumannii isolates 
Antibiotic S (n/%) I (n/%) R (n/%) 
PIP - - 100% (41) 
SXT 13.51% (6) 2.7% (2) 83.78% (35) 
CAZ - 2.7% (2) 97.3% (40) 
IMP 2.7% (2) - 97.3% (40) 
MEM 2.7% (2) - 97.3% (40) 
GN 24.32% (10) 13.51% (6) 62.16% (25) 
NET 27.03% (11) 10.81% (5) 62.16% (25) 
TOB 32.43% (13) - 67.57% (27) 
TIG (N = 35) 20% (8) 80% (30) - 
TZP - 2.7% (2) 97.3% (40) 
COL 97.3% (40) 2.7% (2) - 
LEV - - 100.0% (41) 
PIP: Piperacillin, SXT: Trimethoprim-sulfamethoxazole, CAZ: 
Ceftazidime, IMP: Imipenem, MEM: Meropenem, GN: Gentamicin, 
NET: Netilmicin, TOB: Tobramycin, TIG: Tigecycline, TZP: 
Piperacillin-tazobactam, COL: Colistin, LEV: Levofloxacin 
 
Extended-spectrum β-lactamases (ESBLs) are plasmid-
mediated and produced by Gram-negative bacilli that 
provide resistance to penicillin, cephalosporin and 
monobactams. These ESBLs are commonly found 
worldwide in Enterobacteriaceae, Pseudomonas 
aeruginosa and A. baumannii. Included in ESBL 
members are TEM-, SHV-, or CTX-M-type β-lactamases. 
The CTX-M-type β-lactamases are divided into five 
groups according to amino acid sequence: CTX-M-1, 
CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25 [17]. 
The CTX-M β-lactamases produced by A. baumannii 
strains are plasmid-mediated and therefore find a wide 
distribution in hospitals. In this study, the PCR method 
was used to detect the presence of CTX-M-1 and 
CTX-M-2 β-lactamase encoding genes in the isolates. 
It was determined that 36 strains (87.8%) tested positive 
for blaCTX-M-1 and 18 isolates (43%) tested positive 
for blaCTX-M-2. 
In a multicentre study conducted in 2016 in Turkey, 
443 isolates of A. baumannii were studied, and CTX-
M-1 was identified in 63 isolates and CTX-M-2 in 42 
isolates [18]. The presence of CTX-M-1 and CTX-
M-2 β-lactamases in 96 A. baumannii isolates from 
Turkey was investigated and no positive results were 
obtained for the isolates [19]. In the same study, the 
presence of OXA-23 and OXA-51 class D β-lactamases 
was detected in all strains [19]. 
Similar results were obtained in this study. The presence 
of OXA-51 β-lactamase was detected in all 41 isolates 
and OXA-23 β-lactamase was found in 38 isolates. The 
blaOXA-51 gene is naturally found on the A. baumannii 
chromosome. The blaOXA-23 is plasmid in origin and is 
found in isolates in many countries around the world. 
The presence of the blaOXA-23 gene in clinical isolates 
of A.baumannii from Turkey varies from 31 to 92% 
[19]. In our study, the presence of OXA-40 and OXA-
58 class D β-lactamases was not observed in any of 
the isolates. Of the class A carbapenemases, the GES-
type β-lactamase encoding blaGES was detected in only 
one isolate, whereas none of the class-B β-lactamase 
encoding genes (blaVIM, blaNDM, blaIMP) were found. 
Integrons are genetic elements that recognize and 
capture mobile gene cassettes carrying antimicrobial 
drug resistance determinants. Class 1 integrons are 
associated with multidrug-resistant pathogens. Class 
1 integrons are frequently found in A. baumannii [20]. 
In this study, Class 1 integrons were identified in 34 
of the 41 multidrug-resistant A. baumannii isolates. 
The MIC values of nine plant extracts against six A. 
baumannii isolates with different antibiotic resistance 
phenotypes and genes were determined. The codes 
of the isolates, the resistance genes they carry and 
the MIC values of the plant extracts against these 
isolates are given in Table II. 
Table II 
MIC values of plant extracts against multidrug-resistant isolates 
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Among the plant extracts, Echinacea purpurea was 
found to have the lowest MIC against the multidrug-
resistant A. baumannii isolates. The MIC of Echinacea 
purpurea methanol extract was 2.75 mg/mL for AB38 
and AB45, and 2.25 mg/mL for AB43 and AB46. 
The MIC of Nigella sativa methanol extract was 20 
mg/mL against all studied clinical isolates. It was 
found that the MIC of Hypericum perforatum methanol 
extract for AB38, AB43 and AB45 was 10 mg/mL, 
while this extract did not inhibit the growth of AB46, 
AB59 or AB69 at the tested concentrations. The MIC 
value of Lycium barbarum methanol extract against 
isolates AB38, AB43, AB46 and AB59 was 35 mg/mL 
and 17.5 mg/mL against AB45 and AB69. 
The MIC of Zingiber officinale methanol extract was 
found to be 30 mg/mL for AB38 and AB45 and 15 
mg/mL for AB46 and AB59, whereas it did not 
inhibit the growth of AB43 or AB69 isolates at the 
tested concentrations. The MIC values of the methanol 
extract of Morus alba against AB38, AB43 and AB45 
isolates were determined as 12.5 mg/mL, 50 mg/mL 
and 25 mg/mL, respectively. 
The Rosa canina methanol extract inhibited the growth 
of AB38 alone among the studied isolates. It was 
observed that the methanol extracts of Aquilania 
agalloeha and Vaccinium myrtillus exhibited no anti-
microbial activity against the multidrug-resistant A. 
baumannii clinical isolates (AB38, AB43, AB45, AB46, 
AB59 and AB69) at the concentrations tested. 
Since no new antibiotics have been developed against 
carbapenem-resistant A. baumannii isolates, the anti-
microbial activity of plant-derived substances used in 
traditional medicine has been of particular interest 
[21]. Secondary metabolites are responsible for the 
antimicrobial activities of plants. Various plant active 
compounds with effective activity against A. baumannii 
have been identified worldwide [21]. 
In the present study, the MIC values of nine different 
plant methanol extracts were determined against MDR 
A. baumannii clinical isolates having six different 
resistance gene patterns. In one study, antimicrobial 
activity of methanol, acetone and chloroform extracts 
of Zingiber officinale against MDR A. baumannii 
was investigated [13]. According to the results, the 
chloroform plant extract had the highest activity against 
MDR A. baumannii, with a MIC value of 25 mg/mL. 
In our study, the methanol extract of Zingiber officinale 
was found to have a MIC of 15 mg/mL against MDR 
A. baumannii. In a study conducted by Miyasaki et 
al., the MIC value of Rosa rugosa extract against A. 
baumannii isolates was determined as 50 µg/mL [21, 
22]. In this study, the antimicrobial activity of Rosa 
canina methanol extract on A. baumannii isolates was 
investigated and the MIC value was found to be 35 
mg/mL. Javadian et al. examined the antimicrobial 
activity of Peganum harmala and Heracleum persicum 
against A. baumannii and suggested that extracts obtained 
from both of these might be useful for treating 
bacterial infections [23]. The antibacterial activity of 
Pinus pinaster bark extract against MDR A. baumannii 
isolates was investigated in another study that found 
the extract could be useful in the fight against resistant 
bacteria [24]. In another study, the antibacterial activities 
of Oliveria decumbens, Pelargonium graveolens, Eugenia 
caryophyllata, Ziziphora tenuir and Trachyspermum 
copticum oils were evaluated against 32 clinical isolates 
of A. baumannii. Essential oils of O. decumbens, E. 
caryophyllata and T. copticum were found to have the 
best antibacterial activity against the clinical isolates 
of A. baumannii [25]. Zhang et al. investigated the 
antibacterial activity of Mentha arvensis ethanol extract 
on MDR A. baumannii isolates and found this extract 
to be an effective antibacterial against the isolates [26]. 
This study investigated the antibacterial effect of 
methanol extracts of nine different medicinal plants on 
MDR A. baumannii isolates. According to the results, 
the growth of the isolates harbouring different antibiotic 
resistance genes was inhibited by different plant extracts. 
 
Conclusions 
The emergence of resistant strains of bacterial 
pathogens has resulted in limited treatment options. 
Traditionally, plants play an important role in the 
treatment of diseases and have secondary metabolites 
that are reported to be potentially active against a 
variety of bacteria. Therefore, plants can be used as 
a resource in the search for alternative medicines to 
replace existing antibiotics. 
 
Conflict of interest 
The authors declare no conflict of interest. 
 
References 
1. Kon K, Controlling Bacterial Antibiotic Resistance 
Using Plant-Derived Antimicrobials. In: Upadhyay 
A, Karumathil DP, Upadhyaya I, Bhattaram V, 
Venkitanarayanan K, editors. Antibiotic Resistance 
Mechanisms and New Antimicrobial Approaches. 1st 
ed. Kharkiv, Ukraine: Academic Press; 2016; 205-215. 
2. Sacha P, Wieczorek P, Ojdana D, Czaban S, Klosowska 
W, Jurczak A, Tryniszewska E, Susceptibility, phenotypes 
of resistance, and extended-spectrum β-lactamases in 
Acinetobacter baumannii strains. Folia Histochem 
Cytobiol., 2012; 50(1): 46-51. 
3. Espinal P, Marti S, Vila J, Effect of biofilm 
formation on the survival of Acinetobacter baumannii 
on dry surfaces. J Hosp Infect., 2012; 80(1): 56-60. 
4. Almaghrabi MK, Joseph MRP, Assiry MM, Hamid 
ME, Multidrug-Resistant Acinetobacter baumannii: An 
Emerging Health Threat in Aseer Region, Kingdom 
of Saudi Arabia. Can J Infect Dis Med Microbiol., 
2018; 2018: 9182747: 1-4. 
5. Abdallah EM, Antibacterial activity of Hibiscus 
sabdariffa L. calyces against hospital isolates of multidrug 
resistant Acinetobacter baumannii. J Acute Dis., 2016; 
5(6): 512-516. 
FARMACIA, 2021, Vol. 69, 5 
 918 
6. Peleg AY, Seifert H, Paterson DL, Acinetobacter 
baumannii: emergence of a successful pathogen. Clin 
Microbiol Rev., 2008; 21(3): 538-582. 
7. Pasanen T, Koskela S, Mero S, Tarkka E, Tissari P, 
Vaara M, Kirveskari J, Rapid molecular characterization 
of Acinetobacter baumannii clones with rep-PCR and 
evaluation of carbapenemase genes by new multiplex 
PCR in Hospital District of Helsinki and Uusimaa. 
PLoS One, 2014; 9(1): e85854: 1-8. 
8. Manchanda V, Sanchaita S, Singh N, Multi drug resistant 
Acinetobacter. J Glob Infect Dis., 2010; 2(3): 291-304. 
9. Almasaudi SB, Acinetobacter spp. as nosocomial 
pathogens: Epidemiology and resistance features. Saudi 
J Biol Sci., 2018; 25(3): 586-596. 
10. Manandhar S, Luitel S, Dahal RK, In Vitro Antimicrobial 
Activity of Some Medicinal Plants against Human 
Pathogenic Bacteria. J Trop Med., 2019; 2: 2019: 
1895340: 1-5. 
11. Verma VC, Gond SK, Kumar A, Mishra A, Kharwar 
RN, Gange AC, Endophytic actinomycetes from 
Azadirachta indica A. Juss.: isolation, diversity, and 
anti-microbial activity. Microb Ecol., 2009; 57(4): 
749-756. 
12. Purkayastha S, Dahiya P, Phytochemical analysis 
and antibacterial efficacy of babchi oil (Psoralea 
corylifolia) against multi-drug resistant clinical isolates. 
Int Conf Biosci Biochem Bioinf., 2012; 31: 64-68. 
13. Yeganeh SH, Doost SRH, Goudarzi M, Antimicrobial 
effects of Zingiber officinale extracts against multi-
drug resistant Acinetobacter baumannii clinical isolates 
recovered from hospitalized patients in ICU. J Paramed 
Sci., 2018; 9(3): 42-50. 
14. Copur Cicek A, Saral A, Ozad Duzgun A, Yasar E, 
Cizmeci Z, Ozlem Balci P, Sari F, Firat M, Altintop 
YA, Ak S, Caliskan A, Yildiz N, Sancaktar M, Esra 
Budak E, Erturk A, Birol Ozgumus O, Sandalli C, 
Nationwide study of Escherichia coli producing extended-
spectrum β-lactamases TEM, SHV and CTX-M in 
Turkey. J Antibiot (Tokyo), 2013; 66(11): 647-650. 
15. Cicek AC, Saral A, Iraz M, Ceylan A, Duzgun AO, 
Peleg AY, Sandalli C, OXA- and GES-type β-
lactamases predominate in extensively drug-resistant 
Acinetobacter baumannii isolates from a Turkish 
University Hospital. Clin Microbiol Infect., 2014; 
20(5): 410-415. 
16. Chuah EL, Zakaria ZA, Suhaili Z, Abu Bakar S, 
Desa MNM, Antimicrobial Activities of Plant Extracts 
against Methicillin-Susceptible and Methicillin-Resistant 
Staphylococcus aureus. J Microbiol Res., 2014; 4(1): 
6-13. 
17. Alyamani EJ, Khiyami MA, Booq RY, Alnafjan BM, 
Altammami MA, Bahwerth FS, Molecular characterization 
of extended-spectrum beta-lactamases (ESBLs) produced 
by clinical isolates of Acinetobacter baumannii in Saudi 
Arabia. Ann Clin Microbiol Antimicrob., 2015; 20(14): 
38: 1-9. 
18. Beriş FŞ, Budak EE, Gülek D, Uzun A, Çizmeci Z, 
Mengeloğlu FZ, Direkel Ş, Çetinkol Y, Ay Altıntop Y, 
Iraz M, Dal T, Say Coşkun SU, Balcı PÖ, Kayman 
T, Çalışkan A, Yazıcı Y, Tosun İ, Ertürk A, Çopur 
Çiçek A, Investigation of the frequency and 
distribution of beta-lactamase genes in the clinical 
isolates of Acinetobacter baumannii collected from 
different regions of Turkey: a multicenter study. 
Mikrobiyol Bul., 2016; 50(4): 511-521. 
19. Say Coskun US, Caliskan E, Cicek AC, Turumtay H, 
Sandalli C, β-lactamase genes in carbapenem resistance 
Acinetobacter baumannii isolates from a Turkish 
university hospital. J Infect Dev Ctries., 2019; 13(1): 
50-55. 
20. Eftekhar F, Altayar F, Khidaei H, Plasmid-Mediated 
Class 1 and 2 Integron Carriage in Drug-Resistant 
Nosocomial Isolates of Acinetobacter baumannii. 
Arch Clin Infect Dis., 2018; 13(1): e57813: 1-5. 
21. Tiwari V, Roy R, Tiwari M, Antimicrobial active 
herbal compounds against Acinetobacter baumannii 
and other pathogens. Front Microbiol., 2015; 18(6): 
618: 1-11. 
22. Miyasaki Y, Rabenstein JD, Rhea J, Crouch ML, Mocek 
UM, Kittell PE, Morgan MA, Nichols WS, Van 
Benschoten MM, Hardy WD, Liu GY, Isolation 
and characterization of antimicrobial compounds in 
plant extracts against multidrug-resistant Acinetobacter 
baumannii. PLoS ONE, 2013; 22: 8(4): e61594: 1-8. 
23. Javadian F, Saeidi S, Jahani S, Antimicrobial Activity 
of Peganum harmala and Heracleum persicum against 
Acinetobacter baumannii. Int J Infect., 2016; 3(1): 
e33554: 1-4.  
24. Ćurković-Perica M, Hrenović J, Kugler N, Goić-
Barišić I, Tkalec M, Antibacterial Activity of Pinus 
pinaster bark extract and its components against 
multidrug-resistant clinical isolates of Acinetobacter 
baumannii. Croat Chem Acta, 2015; 88(2): 133-137. 
25. Mahboubi M, Kazempour N, Taghizadeh M, The 
antibacterial activity of some essential oils against clinical 
isolates of Acinetobacter baumannii. Songklanakarin 
J Sci Technol., 2014; 36(5): 513-519. 
26. Zhang L, Xu S, Liang W, Mei J, Di Y, Lan H, Yang 
Y, Wang W, Luo Y, Wang H, Antibacterial activity 
and mode of action of Mentha arvensis ethanol extract 
against multidrug-resistant Acinetobacter baumannii. 
Trop J Pharm Res., 2015; 14(11): 2099-2106. 
 
 
 
